Fairvalue-Calculator Fairvalue-Calculator
EN DE

Medical Properties Trust, Inc (MPT) Fair Value & Analysis

Real Estate · US · Market cap $2.7B

Price$4.51
Fair Value$7.57
Upside+67.8%
Quality95/100
Evidence: High Range $1.80 – $9.86

Fair value as of: Jun 25, 2026

Analysis

Medical Properties Trust, Inc (MPT) currently trades at $4.51, while our model-based Fair Value estimate is $7.57 — implying the stock looks roughly 67.8% undervalued today. We read business quality at 95/100 (high quality), in the Real Estate sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Medical Properties Trust, Inc. is a self-advised real estate investment trust to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 388 facilities and approximately 39,000 licensed beds in nine countries and across three continents as of September 30, 2025. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. Medical Properties Trust, Inc. was incorporated in 2003.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Medical Properties Trust, Inc (MPT) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $7.57 versus a price of $4.51 — about +68% (undervalued). Model-based estimate, not financial advice.
What is the fair value of MPT?
Our 21-model fair value for Medical Properties Trust, Inc is $7.57 (as of Jun 25, 2026), built from audited fundamentals. The current price is $4.51.
What is the quality score of MPT?
Medical Properties Trust, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.